Trial
NCT01113801
A Study in Participants With Diabetic Kidney Disease
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Diabetic Kidney Disease
Intervention
LY2382770
Why stopped
Interim Assessment: Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-17